Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

HitGen

Biotech & Life Sciences · Chengdu, China · Founded 2012 · IPO 2020 Colt

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.43B
Market cap · Apr/2026
Revenue
$59M
Latest reported FY

Investors

2 investors on HitGen's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 2 investors entered at this stage

Global footprint

Where HitGen has talent and traffic

Web traffic by country
3.9K monthly visits
across markets
🇺🇸 United States48.7%
🇯🇵 Japan41%
🇬🇧 United Kingdom5.1%
🇮🇳 India5.1%
Top 4 markets shown

See HitGen on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.